CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 389 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 326-350 of 389 matching filings.

Per page
25
Current page
14
8-K File 001-39126

FORM 8-K

Filing date
16 Sep 2020
Reporting date
16 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
04 Sep 2020
Reporting date
01 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Aug 2020
Reporting date
24 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39126

QUARTERLY REPORT

Filing date
10 Aug 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
S-8 File 333-239998

FORM S-8

Filing date
22 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
25 Jun 2020
Reporting date
25 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2020
Reporting date
12 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2020
Reporting date
12 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2020
Reporting date
12 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jun 2020
Reporting date
12 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
11 Jun 2020
Reporting date
11 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
09 Jun 2020
Reporting date
08 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
28 May 2020
Reporting date
28 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
27 May 2020
Reporting date
27 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
18 May 2020
Reporting date
18 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39126

DEFINITIVE PROXY

Filing date
24 Apr 2020
Reporting date
07 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
C-TR File 020-24084

C-TR filing

Filing date
24 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
26 Mar 2020
Reporting date
20 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
12 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
10 Mar 2020
Reporting date
10 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
02 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
16 Jan 2020
Reporting date
10 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
16 Jan 2020
Reporting date
15 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .